Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.

Kim DK, Cho MH, Hersh CP, Lomas DA, Miller BE, Kong X, Bakke P, Gulsvik A, Agustí A, Wouters E, Celli B, Coxson H, Vestbo J, MacNee W, Yates JC, Rennard S, Litonjua A, Qiu W, Beaty TH, Crapo JD, Riley JH, Tal-Singer R, Silverman EK; ECLIPSE, ICGN, and COPDGene Investigators.

Am J Respir Crit Care Med. 2012 Dec 15;186(12):1238-47. doi: 10.1164/rccm.201206-1013OC. Epub 2012 Nov 9.

2.

Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.

Bowler RP.

COPD. 2012 Dec;9(6):651-3. doi: 10.3109/15412555.2012.736317. Review.

PMID:
23244171
3.

Translating Lung Function Genome-Wide Association Study (GWAS) Findings: New Insights for Lung Biology.

Kheirallah AK, Miller S, Hall IP, Sayers I.

Adv Genet. 2016;93:57-145. doi: 10.1016/bs.adgen.2015.12.002. Epub 2016 Feb 9. Review.

PMID:
26915270
4.

Surfactant protein D in chornic obstructive pulmonary disease (COPD).

Moreno D, Garcia A, Lema D, De Sanctis JB.

Recent Pat Endocr Metab Immune Drug Discov. 2014 Jan;8(1):42-7. Review.

PMID:
24506680
5.

Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD).

Laucho-Contreras ME, Polverino F, Tesfaigzi Y, Pilon A, Celli BR, Owen CA.

Expert Opin Ther Targets. 2016 Jul;20(7):869-83. doi: 10.1517/14728222.2016.1139084. Epub 2016 Feb 11. Review.

6.

Genetic susceptibility to lung cancer and co-morbidities.

Yang IA, Holloway JW, Fong KM.

J Thorac Dis. 2013 Oct;5 Suppl 5:S454-62. doi: 10.3978/j.issn.2072-1439.2013.08.06. Review.

7.

Candidate genes for COPD: current evidence and research.

Kim WJ, Lee SD.

Int J Chron Obstruct Pulmon Dis. 2015 Oct 19;10:2249-55. doi: 10.2147/COPD.S80227. eCollection 2015. Review.

8.

Updates on the COPD gene list.

Bossé Y.

Int J Chron Obstruct Pulmon Dis. 2012;7:607-31. doi: 10.2147/COPD.S35294. Epub 2012 Sep 18. Review.

9.

An integrative functional genomics approach for discovering biomarkers in schizophrenia.

Vawter MP, Mamdani F, Macciardi F.

Brief Funct Genomics. 2011 Nov;10(6):387-99. doi: 10.1093/bfgp/elr036. Epub 2011 Dec 8. Review.

10.

A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation.

Chen YW, Leung JM, Sin DD.

PLoS One. 2016 Jul 19;11(7):e0158843. doi: 10.1371/journal.pone.0158843. eCollection 2016. Review.

11.

Emerging genetics of COPD.

Berndt A, Leme AS, Shapiro SD.

EMBO Mol Med. 2012 Nov;4(11):1144-55. doi: 10.1002/emmm.201100627. Epub 2012 Oct 23. Review.

12.

Inflammatory Markers and the Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

Su B, Liu T, Fan H, Chen F, Ding H, Wu Z, Wang H, Hou S.

PLoS One. 2016 Apr 22;11(4):e0150586. doi: 10.1371/journal.pone.0150586. eCollection 2016. Review.

13.

Genetic polymorphism and chronic obstructive pulmonary disease.

Yuan C, Chang, Lu G, Deng X.

Int J Chron Obstruct Pulmon Dis. 2017 May 10;12:1385-1393. doi: 10.2147/COPD.S134161. eCollection 2017. Review.

14.

Integrative genomics of chronic obstructive pulmonary disease.

Hobbs BD, Hersh CP.

Biochem Biophys Res Commun. 2014 Sep 19;452(2):276-86. doi: 10.1016/j.bbrc.2014.07.086. Epub 2014 Jul 29. Review.

15.

Review: a meta-analysis of GWAS and age-associated diseases.

Jeck WR, Siebold AP, Sharpless NE.

Aging Cell. 2012 Oct;11(5):727-31. doi: 10.1111/j.1474-9726.2012.00871.x. Epub 2012 Aug 30. Review.

16.

[Pathogenesis, diagnosis and treatment of chronic obstructive pulmonary disease in the light of new research].

Płusa T.

Pol Merkur Lekarski. 2016 Dec 22;41(246):263-268. Review. Polish.

PMID:
28024128
17.

Immune-related gene polymorphisms in pulmonary diseases.

Singh DP, Bagam P, Sahoo MK, Batra S.

Toxicology. 2017 May 15;383:24-39. doi: 10.1016/j.tox.2017.03.020. Epub 2017 Mar 30. Review.

PMID:
28366820

Supplemental Content

Support Center